Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Co-therapy comprising canagliflozin and phentermine for the treatment of obesity and obesity related disorders

Co-therapy comprising canagliflozin and phentermine for the treatment of obesity and obesity related disorders

US Patent 11207337 · Granted Dec 28, 2021

Estimated economic value: $192,233,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Small molecule inhibitor of the JAK family of kinases2025
Colon cleansing compositions and method of use2024
Compositions of peptide inhibitors of Interleukin-23 receptor2024
Colonoscopy—preparation2022
Colon cleansing compositions and methods of use2021
Colonoscopy—preparation2020
Colonoscopy-preparation2020
Colonoscopy - preparation2020
Compositions2018
Compositions2017
Colonoscopy—preparation2017
Compositions2016